September 23rd - 24th, 2020
7:45 AM - 5:00 PM ET
Or call 888-224-2480 for fastest service.
You can save an extra 10% off the current rate by using code D10-999-JDS20
This year, the BPCIA turns 10! As we prepare to enter the next decade of this revolutionary law, we cordially invite you to join us for ACI’s 11th Annual Biosimilars & Innovator Biologics Summit, in a fully virtual, interactive format.
What’s new for 2020:
- PTAB Roundtable: The APJs Speak on Practice, Policy and Procedure
- In-House Counsel Town Hall: An Insider’s Guide to What In-House Counsel Expect from Law Firm Counterparts
- Gauging the Impact of COVID-19 Across the Global IP Market: Lessons Learned from the Novel Coronavirus
- Preparing for the Future: Calling Attention to Biologic Products Coming Off-Patent and Devising Forward-Thinking Portfolio Strategies
Exclusive Insights from:
|
|
|
Markus H. Meier
Assistant Director, Health Care Division
Bureau of Competition
U.S. Federal Trade Commission
|
|
|
|
Eva Temkin
Acting Director, Policy Staff
Office of Therapeutic Biologics and Biosimilars
Office of New Drugs, Center for Drug Evaluation and Research
U.S. Food & Drug Administration
|
Industry Acumen from:
- Amgen Inc.
- Apotex Inc.
- Baxter Healthcare Corporation
- Biocon Biologics
- Eisai Inc.
- Fosun Pharma USA
- Fresenius Kabi
View the complete speakers list here
REGISTER NOW and save an extra 10% off the conference by using code D10-999-JDS20.
* Discount is valid for new registration only
